ATLASSyndax Pharmaceuticals (SNDX) earnings date: expected January 18–24
Syndax Pharmaceuticals (SNDX) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around January 18–24. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SNDX
| Last price | $13.06 (-4.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Syndax Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 18–24 (estimate). One email the day before, with ATLAS’s read on Syndax Pharmaceuticals. You can switch it off at any time.
Alert me before SNDX reportsFree to start. Creating an account takes under a minute.
Notify me when Syndax Pharmaceuticals reports
Track SNDX free Add Syndax Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
SNDX earnings at a glance
| Next report | Not announced · expected around January 18–24 (ATLAS estimate) |
|---|---|
| Last report | Nov 2, 2026 |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +6.3% |
| Average move around a report | ±3.3% (last 4) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Syndax Pharmaceuticals’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Syndax Pharmaceuticals earnings history: last 5 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Nov 2, 2026 | -$0.51 | – | – | – | – |
| Aug 4, 2026 | -$0.44 | -$0.55 | -25.0% | Miss | +3.5% |
| Jul 18, 2026 | $0.39 | $0.38 | -2.6% | Miss | -0.7% |
| May 26, 2026 | $2.34 | $3.14 | +34.2% | Beat | -1.7% |
| Apr 30, 2026 | -$0.59 | -$0.48 | +18.6% | Beat | -7.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SNDX
See the fair value, the probability range and the earnings history of Syndax Pharmaceuticals on its ATLAS page.
Syndax Pharmaceuticals (SNDX) stock analysisPlans from €3.99 a month.
Syndax Pharmaceuticals earnings: frequently asked questions
When is Syndax Pharmaceuticals (SNDX) next earnings date?
Syndax Pharmaceuticals has not announced its next report. Its last 3 reports came Nov 2, 2026, Aug 4, 2026, May 26, 2026, so ATLAS estimates the next one around January 18–24. This is an estimate based on that pattern, not a confirmed date.
How often does SNDX beat earnings estimates?
Of its last 4 reports with a recorded result, Syndax Pharmaceuticals beat the EPS estimate 2 times; the average surprise was +6.3%. Past results do not predict the next one.
How much does SNDX move around earnings?
Over its last 4 reports the stock moved an average of 3.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
How much does SNDX usually move in a day?
On a normal trading day the ATLAS model puts SNDX’s one-day range at about ±3.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer